Deletions or insertions in exon 19 and point mutations in exons 18 and 21 in the epidermal growth factor receptor are special diagnostic value in advanced-stage non-small cell lung cancer patients [17,18]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.